Nurofen Apelsin oral suspension

Nurofen is a globally recognized analgesic brand, particularly famous for its ibuprofen-based treatments for pain, fever, and inflammation. Originally launched in the United Kingdom in 1983, it was developed by Boots UK following their discovery of ibuprofen's efficacy. The orange-flavoured (Apelsin) oral suspension shown is specifically formulated for children to provide temporary relief from pain and fever symptoms.

Today, Nurofen is a flagship brand of Reckitt Benckiser (RB), a British multinational consumer goods company. While the brand originated in the UK, manufacturing takes place across a global network of facilities to meet international demand. The corporate ownership has transitioned from the original chemist-developer Boots to the massive Reckitt portfolio, which manages the brand's global distribution and regulatory compliance across various markets, including the Swedish market as indicated by the language on the packaging.